Creatine for Sarcopenia: Why 13 Researchers Just Put It in the Toolbox for Age-Related Muscle Loss

Sarcopenia is the medical name for what most women first notice as a jar that will not open, a suitcase that got heavier, or stairs that suddenly need the railing. Muscle strength, muscle quality and lean mass fall with age, and function follows. This week a group of 13 researchers published an open-access review in the journal Longevity proposing that creatine for sarcopenia deserves a formal place beside protein, vitamin D and resistance training.¹

The author list is the reason to pay attention. Darren Candow, Philip Chilibeck and Scott Forbes have run many of the creatine trials in older adults. Richard Kreider, Jose Antonio and Jeffrey Stout wrote the International Society of Sports Nutrition's position stand on creatine.² When this group titles a paper "one tool in the toolbox," they are describing exactly where they think creatine for sarcopenia fits: the evidence for it, and the gaps still open.

We read the full paper. Here is the whole thing, translated, including the parts that do not flatter the supplement aisle.

What Sarcopenia Is, and Why It Is Not Only an 80-Year-Old's Problem

The review defines sarcopenia as a progressive decline in muscle performance (mainly maximal strength), muscle quality, lean mass and functional ability over time.^1,3 It is no longer a loose description of getting older. It is formally recognised as a muscle disease with its own diagnostic code in the United States and Australia, and it travels with cardiovascular disease, mobility problems, osteoporosis and cognitive impairment.^1,4

About 10 percent of adults 60 and over meet the definition, around 50 million people worldwide, with the exact figure depending on which criteria a study uses.⁵

What is happening inside the muscle matters for everything that follows. Aging preferentially shrinks type II fibers, the fast, powerful fibers you use to catch yourself on a step or lift a case into the car.⁶ Those are also the fibers that store the most creatine, and older adults hold less phosphocreatine (the muscle's rapid energy reserve) than younger adults, with sarcopenic adults holding less still.^1,7 The muscle's response to protein and to training also blunts with age, which researchers call anabolic resistance. So an older muscle receives a weaker signal to grow and has less fuel for the work that would send it.

None of this begins at a diagnosis. A separate 2026 meta-analysis of 608 postmenopausal women puts the typical age-related loss of muscle mass at half a percent to a full percent a year, with accelerated declines in strength and power after menopause.⁸ The trials in the new review start at age 50. The loss they are trying to reverse starts well before that, which is why we have written about it as a perimenopause story in perimenopause weight gain starts with muscle loss and the musculoskeletal syndrome of menopause.

The Numbers Behind Creatine for Sarcopenia

For this paper the authors updated their own meta-analysis. The new version pools 18 randomized, placebo-controlled trials with 792 adults aged 50 and over, all doing resistance training for more than five weeks, half with creatine monohydrate and half with placebo.¹

The result: creatine added 1.18 kg of whole-body lean mass beyond training alone (95 percent confidence interval 0.75 to 1.62 kg, p < 0.0001). Heterogeneity was low, removing any single study did not change the answer, and the funnel plot showed no sign of publication bias.¹ In plain terms, the trials agree with each other, and the result does not depend on one lucky study.

That finding sits on top of eight earlier systematic reviews and meta-analyses, summarised in the paper, that point the same way.

The authors make that connection themselves: improving lean mass matters because it tracks with cardiovascular health, lower fall risk, fewer severe mobility limitations and lower mortality risk in healthy older adults.¹ Beyond whole-body figures, a separate meta-analysis found creatine plus training increased limb muscle thickness measured by ultrasound, and one 52-week trial found it improved lower-leg muscle density, a measure of muscle quality, compared with training alone.¹

Strength, Chair Stands and Walking Speed

Every meta-analysis that measured upper-body strength found creatine beat placebo.¹ Lower-body results were mixed: three analyses found a benefit, three did not. The authors' explanation is worth knowing. Your legs already work all day, so a new training plan is a smaller shock to them, and muscle contraction is what pulls creatine into the fiber. Your upper body, less active day to day, responds to novel training with a bigger creatine uptake.¹

On function, two meta-analyses found the creatine-plus-training combination improved chair-stand performance, the sit-to-stand test that clinicians use to screen for sarcopenia.^9,10 And in the longest trial in the review, two years of creatine at 0.14 g per kg of body weight (about 10 g a day for a 70 kg woman) alongside supervised exercise significantly improved walking speed in older women compared with placebo.¹¹ The authors note it is the only study so far to move a lower-body locomotor measure, and that the dose was high and the duration long, which may be what the legs need.

Individual trials add texture the pooled numbers hide. In one 10-week trial in older adults, strength rose 57 percent with creatine and training against 35.9 percent with training alone.¹² Part of the mechanism is unglamorous and important: older muscle refills its phosphocreatine slowly between efforts, creatine speeds that refill, and people get more work done per session. In one trial in older men, the creatine group trained at 31 percent higher volume than the placebo group.¹³ More work, repeated over months, is where the muscle comes from.

What the Review Says About Women

The one meta-analysis that did not find a lean-mass gain, Dos Santos 2021, pooled seven small trials in women over 60, 142 participants in total.¹⁴ The review's authors give two reasons: the small sample, and the fact that women tend to carry higher creatine concentrations per kilogram of muscle than men at baseline, so a given dose has less headroom to fill.^1,15 That is a useful correction to a line that circulates widely. Women do not have "less" creatine in each muscle fiber. They have less muscle overall. It also means dose and consistency matter more for women, not less.

The women-specific trials the review cites are encouraging, and small. In a study of four vulnerable women over 60 who met the criteria for sarcopenia, 24 weeks of creatine and resistance training reversed the classification in two of them.¹⁶ In seven pre-sarcopenic adults aged 50 and over, five of them women, 32 weeks of creatine and training removed the pre-sarcopenic classification in three of the five women and both men.¹⁷ The authors are direct about the limitation: creatine has been tested in very few people actually diagnosed with sarcopenia, and adequately powered trials are still needed.

The largest women's trial in the review is the two-year study of 237 postmenopausal women, average age 59, that produced the walking-speed result above and most of the safety data below.¹¹ Its direction matches the separate 2026 meta-analysis of 608 postmenopausal women, in which creatine at 5 g a day plus training added lean mass and 7.5 kg of leg-press strength beyond training alone, while the trials using 1 to 3 g a day without training showed no measurable effect.⁸

3 Grams or 5? The Dose Question, Answered by the Trials

The European Food Safety Authority has already accepted one creatine claim for older adults: 3 g a day, combined with resistance training three times a week, improves muscle strength in adults 55 and over.¹⁸ The review is careful about what that covers. It was assessed in healthy older adults, not people with sarcopenia, and it applies to strength only, not lean mass, muscle quality or function.¹

The trials point higher for the outcomes that matter most. In a 14-week trial, 5 g every day in men and women around 69 produced more lean mass and strength than placebo; a similar trial giving about 8.8 g only on training days, three days a week, did not. The authors put the difference down to more frequent, longer dosing, and to differences between the groups studied.^1,26,27 The newest trial in the meta-analysis compared 3 g and 5 g a day during 16 weeks of home resistance-band training in untrained adults over 50. The 5 g group gained more lean mass, though the trial was small and neither arm reached significance on its own.¹⁹ And the largest low-dose trial in older women, 3 g a day for two years with no training, produced no change in muscle, function or bone.²⁰

Our read: 5 g a day, every day, is the dose the evidence converges on for lean mass and strength in this age group. A loading phase (20 g a day for five days) is optional. The review notes loose stools were more common during loading in one trial, so most women will do better skipping it and letting a steady 5 g fill muscle stores over the first few weeks.¹

One more detail from the paper explains why some people feel more from creatine than others. The biggest responders in the research are the people who start with the lowest muscle creatine stores. Vegetarians and vegans sit in that group, and so does anyone who eats little red meat or fish, because a kilogram of meat carries only about 5 g of creatine.^1,21 If that is you, see our list of foods high in creatine and how much of them you would actually need to eat.

One Tool. Here Are the Other Three.

The review's title is a warning against exactly the kind of headline this paper will generate. The authors are explicit that creatine is an addition to the established approach to sarcopenia, not a replacement for it. That approach, recommended by every major sarcopenia society they cite, has three parts.¹

• Protein above 1.0 g per kg of body weight a day. For a 65 kg woman that is 65 g or more, spread across the day. Meta-analyses show raising protein improves lean mass, strength and function in older adults.¹ In one head-to-head trial, whey protein plus creatine during ten weeks of training produced more lean mass and upper-body strength than creatine alone.²²
• Vitamin D, when you are low. Correcting a vitamin D deficiency is part of every sarcopenia guideline the paper reviews. Whether creatine and vitamin D work better together is, in the authors' words, unknown and worth studying.¹
• Structured resistance exercise. This is the stimulus. In frail adults in their nineties, eight weeks of strength training alone raised strength by 174 percent, muscle area by 9 percent and functional performance by 48 percent.²³ Creatine's job is to help you do more of that work and keep more of what it builds.

That third point also explains the review's most cautious section. In two trials of frail and pre-frail older adults, adding creatine to protein and training did not beat protein and training alone.^28,29 The authors' interpretation: in very weak people, training itself produces such large gains that a smaller creatine effect gets buried in them. It is a reminder of the order of operations. Lift first. Eat protein. Then let creatine multiply the result.

The Safety File, Two Years Long

Creatine monohydrate received Generally Recognized as Safe status from the US Food and Drug Administration in 2020. Randomized trials at doses up to 0.14 g per kg a day, about 10 g for a 70 kg adult, running as long as two years, show no greater effect on kidney markers (creatinine clearance, urea, microalbumin) or liver enzymes than placebo in healthy older adults.¹

The two-year trial in 237 postmenopausal women is the clearest example. Out-of-range kidney readings occurred 20 times in 15 women taking creatine and 24 times in 21 women taking placebo. Out-of-range liver readings: nine in seven women on creatine, six in five on placebo.¹¹ In a subset measured for blood pressure, systolic pressure rose 3 mmHg on creatine and 5 mmHg on placebo over the two years.¹ A separate two-year trial at 3 g a day found the same: no difference from placebo on any kidney or liver marker.²⁰

Minor complaints do turn up. In one trial in older men, loose stools were more common during the loading week, and some cramps appeared in weeks three to five, in a group that was also training at 31 percent higher volume.¹³ In a 12-month trial in women around 57, five reported digestive complaints and two reported cramping, against one on placebo, all rated mild to moderate.¹ Neither pattern appeared in the largest and longest trial.

Then there is the creatinine question, which sends a lot of women to a search engine after routine bloodwork. Creatine breaks down into creatinine at a steady rate, so a blood creatinine test reads slightly higher when you supplement. The paper puts the arithmetic plainly: roughly 20 kg of muscle produces about 1 g of creatinine a day, and the kidneys clear it.¹ A higher creatinine on creatine reflects normal metabolism, not damage. Tell your doctor you supplement before the blood draw.

One condition rides with all of this: the safety record belongs to high-purity creatine monohydrate, the pharmaceutical-grade material these trials used. It does not transfer automatically to whatever is in a bag with a creatine label on it. If you want the short version of how to tell the difference, start with what creatine purity actually means.

Who Wrote It, and Who They Work With

The paper's disclosure section is long, and you should know what it says. Several authors advise or have worked with creatine manufacturers, including Alzchem, the German company that makes the Creavitalis® creatine in Stronger. The paper reports that no funding was received for it, four of the 13 authors declare no conflicts at all, and every relationship is listed in the open-access text.¹

We mention it because you would want to know, and because it cuts both ways. These are the people who have spent their careers running the trials, so they know exactly where the evidence is thin, and this paper says so repeatedly: few sarcopenia-diagnosed participants, mixed lower-body results, unknowns around kidney disease and blood pressure. Read it as expert consensus with its ties on the table.

How to Use This Well Before You Are 60

The trials in this review begin at 50, and a sarcopenia diagnosis usually comes later. But muscle lost across the perimenopause years is harder to win back, because the muscle's response to protein and to training keeps blunting with age.¹ So the practical protocol, distilled from the paper, looks the same at 35 as it does at 65.

• Take 5 g of creatine monohydrate every day, training days and rest days alike. In the trials the authors compared, daily dosing did better than training-day-only dosing. Skip the loading phase unless your clinician suggests it.
• Lift something heavy two or three times a week, and keep making it heavier. Progressive resistance training is the stimulus; creatine amplifies it. Bands, dumbbells and machines all count, provided the difficulty keeps rising.
• Eat more than 1.0 g of protein per kg of body weight a day, spread across meals. Creatine plus protein beat creatine alone in a head-to-head trial.
• Ask for a vitamin D level at your next physical, and correct it if it is low. It is one of the three established tools, and the one most people never check.
• Judge it at 12 weeks, not 12 days. The meta-analysis only counted trials longer than five weeks, and the trials described in this article ran 10 weeks to two years. Creatine is not a stimulant; there is nothing to feel on day three. The change shows up in what you can lift and carry.
• Pick a form you will take every day. Consistency is the variable every positive trial in this paper shares.

That last point is why Stronger is a single pre-measured sachet: 5 g of finely micronized Creavitalis® creatine plus marine tripeptide collagen, taurine, rhodiola, hyaluronic acid, and vitamins D3, K2 and C, stirred into water or any drink of choice. If you would rather add creatine on its own to a routine you already have, our micronized Creavitalis® creatine is the same German creatine at the same 5 g serving, and our guide to creatine for women in midlife covers the rest of the research.

Questions We Hear About Creatine and Muscle Loss